BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29207246)

  • 1. Multiple Reaction Monitoring for the Quantitation of Serum Protein Glycosylation Profiles: Application to Ovarian Cancer.
    Miyamoto S; Stroble CD; Taylor S; Hong Q; Lebrilla CB; Leiserowitz GS; Kim K; Ruhaak LR
    J Proteome Res; 2018 Jan; 17(1):222-233. PubMed ID: 29207246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Multiple Reaction Monitoring on QQQ-MS for the Analysis of Protein- and Site-Specific Glycosylation Patterns in Serum.
    Ruhaak LR
    Methods Mol Biol; 2017; 1503():63-82. PubMed ID: 27743359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins.
    Hong Q; Ruhaak LR; Stroble C; Parker E; Huang J; Maverakis E; Lebrilla CB
    J Proteome Res; 2015 Dec; 14(12):5179-92. PubMed ID: 26510530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.
    Ruhaak LR; Kim K; Stroble C; Taylor SL; Hong Q; Miyamoto S; Lebrilla CB; Leiserowitz G
    J Proteome Res; 2016 Mar; 15(3):1002-10. PubMed ID: 26813784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRM validation of targeted nonglycosylated peptides from N-glycoprotein biomarkers using direct trypsin digestion of undepleted human plasma.
    Lee JY; Kim JY; Cheon MH; Park GW; Ahn YH; Moon MH; Yoo JS
    J Proteomics; 2014 Feb; 98():206-17. PubMed ID: 24434586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-Specific Glycosylation Quantitation of 50 Serum Glycoproteins Enhanced by Predictive Glycopeptidomics for Improved Disease Biomarker Discovery.
    Li Q; Kailemia MJ; Merleev AA; Xu G; Serie D; Danan LM; Haj FG; Maverakis E; Lebrilla CB
    Anal Chem; 2019 Apr; 91(8):5433-5445. PubMed ID: 30882205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to quantifying N-linked glycoproteins by enzyme-catalyzed 18O3-labeling of solid-phase enriched glycopeptides.
    Shakey Q; Bates B; Wu J
    Anal Chem; 2010 Sep; 82(18):7722-8. PubMed ID: 20795641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma.
    Lee JY; Kim JY; Park GW; Cheon MH; Kwon KH; Ahn YH; Moon MH; Lee HJ; Paik YK; Yoo JS
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.009290. PubMed ID: 21940909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites.
    Alvarez-Manilla G; Atwood J; Guo Y; Warren NL; Orlando R; Pierce M
    J Proteome Res; 2006 Mar; 5(3):701-8. PubMed ID: 16512686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.
    Darebna P; Novak P; Kucera R; Topolcan O; Sanda M; Goldman R; Pompach P
    J Proteomics; 2017 Feb; 153():44-52. PubMed ID: 27646713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry.
    Ahn YH; Lee JY; Lee JY; Kim YS; Ko JH; Yoo JS
    J Proteome Res; 2009 Sep; 8(9):4216-24. PubMed ID: 19645485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.
    Wu J; Xie X; Liu Y; He J; Benitez R; Buckanovich RJ; Lubman DM
    J Proteome Res; 2012 Sep; 11(9):4541-52. PubMed ID: 22827608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.
    Ma J; Sanda M; Wei R; Zhang L; Goldman R
    J Proteomics; 2018 Oct; 189():67-74. PubMed ID: 29427759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
    Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
    Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatography coupled to mass spectrometry methodology for analyzing site-specific N-glycosylation patterns.
    Ozohanics O; Turiák L; Puerta A; Vékey K; Drahos L
    J Chromatogr A; 2012 Oct; 1259():200-12. PubMed ID: 22677411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.
    Bongers J; Devincentis J; Fu J; Huang P; Kirkley DH; Leister K; Liu P; Ludwig R; Rumney K; Tao L; Wu W; Russell RJ
    J Chromatogr A; 2011 Nov; 1218(45):8140-9. PubMed ID: 21978954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry.
    Harazono A; Kawasaki N; Itoh S; Hashii N; Matsuishi-Nakajima Y; Kawanishi T; Yamaguchi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):20-30. PubMed ID: 18514042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assigning N-glycosylation sites of glycoproteins using LC/MSMS in conjunction with endo-M/exoglycosidase mixture.
    Segu ZM; Hussein A; Novotny MV; Mechref Y
    J Proteome Res; 2010 Jul; 9(7):3598-607. PubMed ID: 20405899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct analysis of site-specific N-glycopeptides of serological proteins in dried blood spot samples.
    Choi NY; Hwang H; Ji ES; Park GW; Lee JY; Lee HK; Kim JY; Yoo JS
    Anal Bioanal Chem; 2017 Aug; 409(21):4971-4981. PubMed ID: 28681077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Robust and Versatile Automated Glycoanalytical Technology for Serum Antibodies and Acute Phase Proteins: Ovarian Cancer Case Study.
    O'Flaherty R; Muniyappa M; Walsh I; Stöckmann H; Hilliard M; Hutson R; Saldova R; Rudd PM
    Mol Cell Proteomics; 2019 Nov; 18(11):2191-2206. PubMed ID: 31471495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.